Lineage Cell Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | $17.2M | $45.8M | $22.2M |
| FY2012 | $20.2M | $29.7M | $4.4M |
| FY2013 | $42.9M | $57.7M | $5.5M |
| FY2014 | $38.4M | $74.9M | $29.5M |
| FY2015 | $18.2M | $94.7M | $42.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | $17.2M | $45.8M | $22.2M |
| FY2012 | $20.2M | $29.7M | $4.4M |
| FY2013 | $42.9M | $57.7M | $5.5M |
| FY2014 | $38.4M | $74.9M | $29.5M |
| FY2015 | $18.2M | $94.7M | $42.2M |